The V2 vasopressin receptor mutations and fluid homeostasis

被引:21
作者
Birnbaumer, M [1 ]
机构
[1] Univ Calif Los Angeles, Sch Med, Dept Anesthesiol & Physiol, Los Angeles, CA 90095 USA
关键词
diabetes; hormones; intra/extracellular ions; receptors; vasoactive agents;
D O I
10.1016/S0008-6363(01)00337-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although three different G-protein coupled receptors have been identified for arginine vasopressin, a significant physiological role has been recognized only for the V2 subtype that controls water homeostasis. Identification of the gene encoding the V2 vasopressin (or antidiuretic hormone) receptor enabled researchers to test the hypothesis that mutations of this gene were responsible for X-linked recessive nephrogenic diabetes insipidus. The affected patients are unable to concentrate their urine and as a consequence live in constant danger of dehydration that can cause death, particularly in infancy, or lead to severe hypernatremia that can impair their intellectual and physical development. The danger of severe dehydration diminishes in the adult patients, although they remain highly susceptible to this condition for the rest of their lives. (C) 2001 Elsevier Science BY. All rights reserved.
引用
收藏
页码:409 / 415
页数:7
相关论文
共 46 条
  • [22] KNEPPER MA, 2000, HDB PHYSL, V3, P496
  • [23] KNOERS NVM, 1994, TRENDS ENDOCRIN MET, V7, P422
  • [24] GENE-TRANSFER, EXPRESSION, AND MOLECULAR-CLONING OF THE HUMAN TRANSFERRIN RECEPTOR GENE
    KUHN, LC
    MCCLELLAND, A
    RUDDLE, FH
    [J]. CELL, 1984, 37 (01) : 95 - 103
  • [25] MOLECULAR-CLONING AND EXPRESSION OF A RAT VIA ARGININE VASOPRESSIN RECEPTOR
    MOREL, A
    OCARROLL, AM
    BROWNSTEIN, MJ
    LOLAIT, SJ
    [J]. NATURE, 1992, 356 (6369) : 523 - 526
  • [26] Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants
    Morello, JP
    Salahpour, A
    Laperrière, A
    Bernier, V
    Arthus, MF
    Lonergan, M
    Petäjä-Repo, U
    Angers, S
    Morin, D
    Bichet, DG
    Bouvier, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (07) : 887 - 895
  • [27] OHNISHI A, 1995, J PHARMACOL EXP THER, V272, P546
  • [28] Oksche A, 1996, MOL PHARMACOL, V50, P820
  • [29] ORLOFF J, 1962, J CLIN INVEST, V47, P1154
  • [30] Reeves WB, 1995, METABOLIC BASIS INHE, P3045